Streptococcal Pneumonia - Pipeline Review, H1 2016

  • ID: 3774210
  • Report
  • 139 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Abera Bioscience AB
  • Arsanis Biosciences GmbH
  • Eurocine Vaccines AB
  • ImmunoBiology Limited
  • Mucosis B.V.
  • Sanofi Pasteur SA
  • MORE
Streptococcal Pneumonia - Pipeline Review, H1 2016

Summary

‘Streptococcal Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Streptococcal Pneumonia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Streptococcal Pneumonia and features dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Streptococcal Pneumonia
- The report reviews pipeline therapeutics for Streptococcal Pneumonia by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Streptococcal Pneumonia therapeutics and enlists all their major and minor projects
- The report assesses Streptococcal Pneumonia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Streptococcal Pneumonia

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Streptococcal Pneumonia
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Streptococcal Pneumonia pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abera Bioscience AB
  • Arsanis Biosciences GmbH
  • Eurocine Vaccines AB
  • ImmunoBiology Limited
  • Mucosis B.V.
  • Sanofi Pasteur SA
  • MORE
Introduction

Streptococcal Pneumonia Overview

Therapeutics Development

Streptococcal Pneumonia - Therapeutics under Development by Companies

Streptococcal Pneumonia - Therapeutics under Investigation by Universities/Institutes

Streptococcal Pneumonia - Pipeline Products Glance

Streptococcal Pneumonia - Products under Development by Companies

Streptococcal Pneumonia - Products under Investigation by Universities/Institutes

Streptococcal Pneumonia - Companies Involved in Therapeutics Development

Streptococcal Pneumonia - Therapeutics Assessment

Drug Profiles

Streptococcal Pneumonia - Recent Pipeline Updates

Streptococcal Pneumonia - Dormant Projects

Streptococcal Pneumonia - Discontinued Products

Streptococcal Pneumonia - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Streptococcal Pneumonia, H1 2016

Number of Products under Development for Streptococcal Pneumonia - Comparative Analysis, H1 2016

Number of Products under Development by Companies, H1 2016

Number of Products under Development by Companies, H1 2016 (Contd..1)

Number of Products under Investigation by Universities/Institutes, H1 2016

Comparative Analysis by Late Stage Development, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Development, H1 2016

Products under Development by Companies, H1 2016

Products under Development by Companies, H1 2016 (Contd..1)

Products under Investigation by Universities/Institutes, H1 2016

Streptococcal Pneumonia - Pipeline by Abera Bioscience AB, H1 2016

Streptococcal Pneumonia - Pipeline by Actelion Ltd, H1 2016

Streptococcal Pneumonia - Pipeline by Alvogen Korea Co., Ltd., H1 2016

Streptococcal Pneumonia - Pipeline by Arsanis Biosciences GmbH, H1 2016

Streptococcal Pneumonia - Pipeline by AstraZeneca Plc, H1 2016

Streptococcal Pneumonia - Pipeline by Beijing Minhai Biotechnology Co., Ltd, H1 2016

Streptococcal Pneumonia - Pipeline by ContraFect Corporation, H1 2016

Streptococcal Pneumonia - Pipeline by Daiichi Sankyo Company, Limited, H1 2016

Streptococcal Pneumonia - Pipeline by Eurocine Vaccines AB, H1 2016

Streptococcal Pneumonia - Pipeline by FluGen, Inc., H1 2016

Streptococcal Pneumonia - Pipeline by GlaxoSmithKline Plc, H1 2016

Streptococcal Pneumonia - Pipeline by ImmunoBiology Limited, H1 2016

Streptococcal Pneumonia - Pipeline by Lascco SA, H1 2016

Streptococcal Pneumonia - Pipeline by Liquidia Technologies, Inc., H1 2016

Streptococcal Pneumonia - Pipeline by Merck & Co., Inc., H1 2016

Streptococcal Pneumonia - Pipeline by Mucosis B.V., H1 2016

Streptococcal Pneumonia - Pipeline by Panacea Biotec Limited, H1 2016

Streptococcal Pneumonia - Pipeline by Prometheon Pharma, LLC, H1 2016

Streptococcal Pneumonia - Pipeline by Sanofi Pasteur SA, H1 2016

Streptococcal Pneumonia - Pipeline by Serum Institute of India Limited, H1 2016

Streptococcal Pneumonia - Pipeline by SK Chemicals Co., Ltd., H1 2016

Streptococcal Pneumonia - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H1 2016

Streptococcal Pneumonia - Pipeline by Valneva SE, H1 2016

Streptococcal Pneumonia - Pipeline by Vaxxilon AG, H1 2016

Streptococcal Pneumonia - Pipeline by Virometix AG, H1 2016

Streptococcal Pneumonia - Pipeline by Walvax Biotechnology Co., Ltd., H1 2016

Streptococcal Pneumonia - Pipeline by Wellstat Vaccines, LLC, H1 2016

Streptococcal Pneumonia - Pipeline by Wockhardt Limited, H1 2016

Assessment by Monotherapy Products, H1 2016

Assessment by Combination Products, H1 2016

Number of Products by Stage and Target, H1 2016

Number of Products by Stage and Mechanism of Action, H1 2016

Number of Products by Stage and Route of Administration, H1 2016

Number of Products by Stage and Molecule Type, H1 2016

Streptococcal Pneumonia Therapeutics - Recent Pipeline Updates, H1 2016

Streptococcal Pneumonia - Dormant Projects, H1 2016

Streptococcal Pneumonia - Dormant Projects (Contd..1), H1 2016

Streptococcal Pneumonia - Dormant Projects (Contd..2), H1 2016

Streptococcal Pneumonia - Dormant Projects (Contd..3), H1 2016

Streptococcal Pneumonia - Discontinued Products, H1 2016

List of Figures

Number of Products under Development for Streptococcal Pneumonia, H1 2016

Number of Products under Development for Streptococcal Pneumonia - Comparative Analysis, H1 2016

Number of Products under Development by Companies, H1 2016

Number of Products under Investigation by Universities/Institutes, H1 2016

Comparative Analysis by Late Stage Development, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Products, H1 2016

Assessment by Monotherapy Products, H1 2016

Number of Products by Top 10 Targets, H1 2016

Number of Products by Stage and Top 10 Targets, H1 2016

Number of Products by Top 10 Mechanism of Actions, H1 2016

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016

Number of Products by Routes of Administration, H1 2016

Number of Products by Stage and Routes of Administration, H1 2016

Number of Products by Top 10 Molecule Types, H1 2016

Number of Products by Stage and Top 10 Molecule Types, H1 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Abera Bioscience AB
Actelion Ltd
Alvogen Korea Co., Ltd.
Arsanis Biosciences GmbH
AstraZeneca Plc
Beijing Minhai Biotechnology Co., Ltd
ContraFect Corporation
Daiichi Sankyo Company, Limited
Eurocine Vaccines AB
FluGen, Inc.
GlaxoSmithKline Plc
ImmunoBiology Limited
Lascco SA
Liquidia Technologies, Inc.
Merck & Co., Inc.
Mucosis B.V.
Panacea Biotec Limited
Prometheon Pharma, LLC
Sanofi Pasteur SA
Serum Institute of India Limited
SK Chemicals Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Valneva SE
Vaxxilon AG
Virometix AG
Walvax Biotechnology Co., Ltd.
Wellstat Vaccines, LLC
Wockhardt Limited
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll